Table of Contents

Clinical Investigations

• You have access

  Somatostatin Receptor–Targeted Radiopeptide Therapy with ⁹⁰Y-DOTATOC and ¹⁷⁷Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial

  Nicolas Marincek, Piotr Radojewski, Rebecca A. Dumont, Philippe Brunner, Jan Müller-Brand, Helmut R. Maecke, Matthias Briel and Martin A. Walter

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 171-176; DOI: https://doi.org/10.2967/jnumed.114.147256
• You have access

  Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using ¹⁷⁷Lu-DOTATATE

  Ezgi Ilan, Mattias Sandström, Cecilia Wassberg, Anders Sundin, Ulrike Garske–Román, Barbro Eriksson, Dan Granberg and Mark Lubberink

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 177-182; DOI: https://doi.org/10.2967/jnumed.114.148437
• You have access

  Risk Stratification of Metastatic Neck Nodes by CT and PET in Patients with Head and Neck Cancer Receiving Definitive Radiotherapy

  Ying-Chun Lin, Shang-Wen Chen, Te-Chun Hsieh, Kuo-Yang Yen, Shih-Neng Yang, Yao-Ching Wang and Chia-Hung Kao

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 183-189; DOI: https://doi.org/10.2967/jnumed.114.148023
• You have access

  Differentiated Thyroid Cancer Patients More Than 60 Years Old Paradoxically Show an Increased Life Expectancy

  Tobias Markus Maier, Otmar Schober, Joachim Gerß, Dennis Görlich, Christian Wenning, Michael Schaefers, Burkhard Riemann and Alexis Vrachimis

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 190-195; DOI: https://doi.org/10.2967/jnumed.114.150284
• You have access

  Areas of High ¹⁸F-FDG Uptake on Preradiotherapy PET/CT Identify Preferential Sites of Local Relapse After Chemoradiotherapy for Non–Small Cell Lung Cancer

  Jérémie Calais, Sébastien Thureau, Bernard Dubray, Romain Modzelewski, Luc Thiberville, Isabelle Gardin and Pierre Vera

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 196-203; DOI: https://doi.org/10.2967/jnumed.114.144253
• You have access

  ¹⁸F-FDG PET/CT and Lung Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management

  Charles Marcus, Vasavi Paidpally, Alexander Antoniou, Atif Zaheer, Richard L. Wahl and Rathan M. Subramaniam

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 204-208; DOI: https://doi.org/10.2967/jnumed.114.147884
• You have access

  Gleason Score at Diagnosis Predicts the Rate of Detection of ¹⁸F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients

  Marino Cimitan, Laura Evangelista, Marina Hodolič, Giuliano Mariani, Tanja Baseric, Valentina Bodanza, Giorgio Saladini, Duccio Volterrani, Anna Rita Cervino, Michele Gregianin, Giulia Puccini, Federica Guidoccio, Jure Fettich and Eugenio Borsatti

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 209-215; DOI: https://doi.org/10.2967/jnumed.114.141887
• You have access

  ¹⁸F-FDG or 3′-Deoxy-3′-¹⁸F-Fluorothymidine to Detect Transformation of Follicular Lymphoma

  Marielle J. Wondergem, Saiyada N.F. Rizvi, Yvonne Jauw, Otto S. Hoekstra, Nikie Hoetjes, Peter M. van de Ven, Ronald Boellaard, Martine E.D. Chamuleau, Saskia A.G.M. Cillessen, Josien C. Regelink, Sonja Zweegman and Josée M. Zijlstra

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 216-221; DOI: https://doi.org/10.2967/jnumed.114.149625
• You have access

  ¹⁸F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry

  Bruce E. Hillner, Barry A. Siegel, Lucy Hanna, Fenghai Duan, Bruce Quinn and Anthony F. Shields

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 222-228; DOI: https://doi.org/10.2967/jnumed.114.150391
• You have access

  Relationship Between Alzheimer Disease–Like Pattern of ¹⁸F-FDG and Fasting Plasma Glucose Levels in Cognitively Normal Volunteers

  Kenji Ishibashi, Airin Onishi, Yoshinori Fujiwara, Kiichi Ishiwata and Kenji Ishii

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 229-233; DOI: https://doi.org/10.2967/jnumed.114.150045
• You have access

  Use of ¹¹C-PE2I PET in Differential Diagnosis of Parkinsonian Disorders

  Lieuwe Appel, My Jonasson, Torsten Danfors, Dag Nyholm, Håkan Askmark, Mark Lubberink and Jens Sörensen

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 234-242; DOI: https://doi.org/10.2967/jnumed.114.148619
• You have access

  Test–Retest Reproducibility of Binding Parameters in Humans with ¹¹C-LY2795050, an Antagonist PET Radiotracer for the κ Opioid Receptor

  Mika Naganawa, Ming-Qiang Zheng, Shannan Henry, Nabeel Nabulsi, Shu-Fei Lin, Jim Ropchan, David Labaree, Soheila Najafzadeh, Michael Kapinos, Johannes Tauscher, Alexander Neumeister, Richard E. Carson and Yiyun Huang

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 243-248; DOI: https://doi.org/10.2967/jnumed.114.147975
• You have access

  PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of ⁸⁹Zr-Cetuximab

  Nikolaos E. Makris, Ronald Boellaard, Arthur van Lingen, Adriaan A. Lammertsma, Guus A.M.S. van Dongen, Henk M. Verheul, Catharina W. Menke and Marc C. Huisman

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 249-254; DOI: https://doi.org/10.2967/jnumed.114.147819
• You have access

  Integrated ¹⁸F-FDG PET/MR Imaging in the Assessment of Cardiac Masses: A Pilot Study

  Felix Nensa, Ercan Tezgah, Thorsten D. Poeppel, Christoph J. Jensen, Juliane Schelhorn, Jens Köhler, Philipp Heusch, Oliver Bruder, Thomas Schlosser and Kai Nassenstein

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 255-260; DOI: https://doi.org/10.2967/jnumed.114.147744
• You have access

  Motion Correction Strategies for Integrated PET/MR

  Sebastian Fürst, Robert Grimm, Inki Hong, Michael Souvatzoglou, Michael E. Casey, Markus Schwaiger, Stephan G. Nekolla and Sibylle I. Ziegler

  Journal of Nuclear Medicine February 1, 2015, 56 (2) 261-269; DOI: https://doi.org/10.2967/jnumed.114.146787